The price of traditional Chinese medicine will continue to rise, or it will become "noble medicine"
-
Last Update: 2017-05-31
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
[market analysis of chinapharma.com] the supply and price increase of upstream traditional Chinese medicine directly affect the downstream traditional Chinese medicine enterprises The sharp price increase of famous traditional Chinese medicine such as Pianzihuang and dong'a gum is directly related to the shortage of raw materials and the soaring price It can be predicted that this round of soaring prices of traditional Chinese medicine will have a significant and sustained impact on traditional Chinese medicine On May 27, Zhangzhou pianzehuang Pharmaceutical Co., Ltd issued a notice In view of the increase in the main raw materials and labor costs of pianzehuang products, the company decided to increase the retail price of the company's leading product pianzehuang from 500 yuan / capsule to 530 yuan / capsule, and the supply price will be increased accordingly In fact, this is the 14th retail price increase since 2005 As a national confidential variety, the price of Pianzihuang has increased from 125 yuan / grain in 2005 to 530 yuan / grain now, which has more than quadrupled Let's review the course of price adjustment since 2005: in addition to the skyrocketing price of traditional Chinese medicine, the price of traditional Chinese medicine is now soaring on the tuyere, as well as the price of dong'a gum In the past decade, after 16 price adjustments, its price has increased by more than 54 times Before that, shortly after the price rise of dong'a gum and Pianzihuang, the supply price of Musk Hemorrhoids cream, a Chinese patent medicine owned by Ma Yinglong, another well-known listed pharmaceutical company, increased by 18% Guangyuyuan will also raise the price of Angong Niuhuang Pill and other products in the near future Before that, dingkundan, its fist product, has raised the price by 15% to 20% Especially after the opening of drug price, the phenomenon of rising price of Chinese patent medicine is more and more common As we all know, the shortage of raw materials and soaring prices are the key factors The supply and price rise of upstream traditional Chinese medicine also directly affect the downstream traditional Chinese medicine enterprises As mentioned above, the sharp price increase of famous Chinese patent medicines such as Pianzihuang and dong'a-jiao is directly related to the shortage of raw materials and the sharp rise of prices Take Pianzihuang for example, a Pianzihuang weighs 3 grams, containing about 0.09 grams of natural musk According to the company's annual output of about 2.5 million grains, it is estimated that it is necessary to raise at least 18000 male musk deer to produce musk so as to ensure the normal production of the traditional secret medicine Pianzihuang According to the relevant data, Pianzihuang began to intervene in the artificial musk deer industry in 2007 Through the mode of "base + farmer", about 1500 musk deer were raised There is a huge raw material gap between the production capacity demand of 18000 and the breeding scale of 1500 Therefore, it is not difficult to understand the reasons why the price of zizihuang keeps rising For the continuous increase in the price of Pianzihuang, many securities companies believe that the price increase is expected to continue After the implementation of the new pharmacopoeia, the quality supervision of traditional Chinese medicine is more strict Due to the increased cost of processing and storage, sulfur-free medicine will drive up its own price In addition, due to the current national flying inspection storm, sulfur-free medicine has become a short supply in the market, greatly raising the price of sulfur-free medicine For some varieties, the price of sulfur-free medicine has been twice that of sulfur-containing medicine It is estimated that The price of traditional Chinese medicine will rise further and continue to raise the cost of traditional Chinese medicine enterprises A group of Chinese herbal medicines represented by Panax notoginseng, Evodia rutaecarpa and Atractylodes macrocephala have doubled or even more than tripled their annual growth It can be predicted that this round of soaring prices of traditional Chinese medicine has a significant and sustained impact on traditional Chinese medicine In the future, with the help of policy support and strict drug quality control, the prices of traditional Chinese medicine, Chinese herbal pieces and Chinese patent medicines may continue to rise, and the days of traditional Chinese medicine becoming "noble medicine" are not far away.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.